Literature DB >> 8453454

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study.

S P Morrissey1, D H Miller, B E Kendall, D P Kingsley, M A Kelly, D A Francis, D G MacManus, W I McDonald.   

Abstract

A 5-year follow-up study was performed on 89 patients who had undergone brain magnetic resonance imaging (MRI) at presentation with an acute clinically isolated syndrome of the optic nerves, brainstem or spinal cord of a type suggestive of multiple sclerosis. At presentation, MRI was abnormal, revealing one or more asymptomatic cerebral white matter lesions in 57 (64%), and was normal in 32 (36%). At follow-up, progression to clinically definite multiple sclerosis had occurred in 37 out of 57 (65%) with an abnormal MRI and one out of 32 (3%) with normal MRI. Human leucocyte antigen (HLA) typing was performed in 70 patients and cerebrospinal fluid (CSF) was examined at presentation in 36. The presence of HLA-DR2 antigen or cerebrospinal fluid oligoclonal IgG bands were both associated with a significantly increased risk of progression to multiple sclerosis, but MRI was much more powerful in predicting outcome. The presence of four or more MRI lesions at presentation was associated with a higher rate of progression to multiple sclerosis, more frequent development of moderate or severe disabilities and a greater number of new MRI lesions at follow-up. The results indicate that brain MRI at presentation with a clinically isolated syndrome suggestive of multiple sclerosis is a powerful predictor of the clinical course over the next 5 years. This observation, combined with an ability to detect other sometimes treatable disorders which can also cause such syndromes, suggests that MRI is the investigation of choice in evaluating this group of patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453454     DOI: 10.1093/brain/116.1.135

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  72 in total

1.  Lack of restriction of T cell receptor beta variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis.

Authors:  R N Heard; S M Teutsch; B H Bennetts; S D Lee; E M Deane; G J Stewart
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

2.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

Review 3.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

Review 4.  Early-stage multiple sclerosis : what are the treatment options?

Authors:  Per Soelberg Sorensen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI.

Authors:  A Ghezzi; V Torri; M Zaffaroni
Journal:  Ital J Neurol Sci       Date:  1996-10

6.  MR imaging of optic neuropathy with extended echo-train acquisition fluid-attenuated inversion recovery.

Authors:  A H Aiken; P Mukherjee; A J Green; C M Glastonbury
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

7.  Neuro-ophthalmology for neuroradiologists.

Authors:  D A Jacobs; S L Galetta
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

8.  Cranial MRI in idiopathic retinal vasculitis.

Authors:  A Gass; E Graham; I F Moseley; M Stanford; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

Review 9.  Vitamin D for the treatment of multiple sclerosis: a meta-analysis.

Authors:  Laurie McLaughlin; Laura Clarke; Elham Khalilidehkordi; Helmut Butzkueven; Bruce Taylor; Simon A Broadley
Journal:  J Neurol       Date:  2018-10-03       Impact factor: 4.849

10.  Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.

Authors:  René-Maxime Gracien; Sarah C Reitz; Stephanie Michelle Hof; Vinzenz Fleischer; Hilga Zimmermann; Amgad Droby; Helmuth Steinmetz; Frauke Zipp; Ralf Deichmann; Johannes C Klein
Journal:  Eur Radiol       Date:  2015-10-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.